Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (8 quarters reported)
$116M in Q4 2016 → $29M now. Hover for any quarter.
As reported for the quarter ended September 30, 2018. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Allena Pharmaceuticals | 32.3% | Trimmed 0.6% | 873,031 | $9.38M |
| Protagonist Therapeutics, Inc. | 26.6% | Unchanged | 750,632 | $7.72M |
| NT Neon Therapeutics Inc. | 17.3% | New | 588,611 | $5.03M |
| JT Jounce Therapeutics, Inc. | 12.6% | Unchanged | 565,063 | $3.67M |
| PT Proteon Therapeutics Inc. | 10.8% | Unchanged | 1,607,807 | $3.14M |
| AT Argos Therapeutics Inc. | 0.3% | Unchanged | 826,153 | $83K |
| AT Argos Therapeutics Inc. Call | 0.1% | Unchanged | 256,030 | $26K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 7 quarters.
quarter ended September 30, 2018 · filed November 15, 2018
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| NT Neon Therapeutics Inc. | New | +588,611 | +$5.03M | 17.3% |
| Allena Pharmaceuticals | Trimmed | −5,100 | −$54.8K | 32.3% |
quarter ended June 30, 2018 · filed August 14, 2018
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Allena Pharmaceuticals | Trimmed | −159,136 | −$2.07M | 45.9% |
| Protagonist Therapeutics, Inc. | Trimmed | −231,638 | −$1.56M | 20.2% |
| JT Jounce Therapeutics, Inc. | Trimmed | −97,000 | −$743K | 17.4% |
| PT Proteon Therapeutics Inc. | Trimmed | −60,100 | −$147K | 15.8% |
quarter ended March 31, 2018 · filed May 15, 2018
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AT Argos Therapeutics Inc. | Trimmed | −12,316,631 | −$11.1M | 1.9% |
| AT Argos Therapeutics Inc. | Trimmed | −4,864,574 | −$4.37M | 0.6% |
quarter ended December 31, 2017 · filed February 14, 2018
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Allena Pharmaceuticals | New | +1,037,267 | +$10.4M | 10.7% |
| AT Argos Therapeutics Inc. | Trimmed | −99,495 | −$298K | 40.5% |
quarter ended September 30, 2017 · filed November 03, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| PT Proteon Therapeutics Inc. | Added | +502,563 | +$1.01M | 9.7% |
quarter ended June 30, 2017 · filed August 15, 2017
No position changes this quarter.
quarter ended March 31, 2017 · filed August 17, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| JT Jounce Therapeutics | New | +662,063 | +$14.6M | 38.8% |
| PT Protagonist Therapeutic, Inc. | Trimmed | −1,300 | −$16.7K | 33.6% |
Loading...
